Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
DSCI [NASD]
Derma Sciences Inc.
Index- P/E- EPS (ttm)-1.58 Insider Own2.60% Shs Outstand25.72M Perf Week-4.09%
Market Cap168.72M Forward P/E- EPS next Y-1.36 Insider Trans-2.70% Shs Float24.22M Perf Month-17.90%
Income-40.10M PEG- EPS next Q-0.42 Inst Own87.50% Short Float3.81% Perf Quarter-20.48%
Sales83.50M P/S2.02 EPS this Y-15.70% Inst Trans1.80% Short Ratio8.08 Perf Half Y-22.27%
Book/sh4.63 P/B1.42 EPS next Y20.50% ROA-27.90% Target Price15.00 Perf Year-32.37%
Cash/sh2.59 P/C2.54 EPS next 5Y- ROE-30.70% 52W Range6.39 - 12.02 Perf YTD-29.54%
Dividend- P/FCF- EPS past 5Y-45.30% ROI-31.80% 52W High-45.34% Beta0.88
Dividend %- Quick Ratio7.10 Sales past 5Y11.50% Gross Margin36.90% 52W Low2.82% ATR0.30
Employees299 Current Ratio8.50 Sales Q/Q-1.50% Oper. Margin-47.90% RSI (14)28.15 Volatility5.27% 3.80%
OptionableYes Debt/Eq0.00 EPS Q/Q0.00% Profit Margin-48.00% Rel Volume0.54 Prev Close6.56
ShortableYes LT Debt/Eq0.00 EarningsMay 11 BMO Payout- Avg Volume114.37K Price6.57
Recom1.80 SMA20-8.80% SMA50-17.14% SMA200-21.87% Volume22,094 Change0.15%
Aug-14-14Reiterated Oppenheimer Outperform $19 → $18
Mar-17-14Reiterated Oppenheimer Outperform $19 → $21
Jul-06-11Initiated Oppenheimer Outperform $21
Feb-09-11Reiterated Rodman & Renshaw Mkt Outperform $13 → $25
May-14-10Initiated Rodman & Renshaw Mkt Outperform $13
May-19-15 07:30AM  Derma Sciences Provides Update on Aclerastide Phase 3 Trials Business Wire
May-15-15 01:04PM  DERMA SCIENCES, INC. Financials
May-11-15 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:15AM  Derma Sciences reports 1Q loss
07:07AM  Q1 2015 Derma Sciences Inc Earnings Release - Before Market Open
07:00AM  Derma Sciences Reports First Quarter 2015 Financial Results Business Wire
May-08-15 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
May-05-15 05:43PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11Th at noodls
03:32PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11Th Business Wire
Apr-30-15 09:46AM  Derma Sciences to Present Clinical Data Demonstrating Efficacy in Tissue Regeneration at the Spring Symposium on Advanced Wound Care at noodls
09:00AM  Derma Sciences to Present Clinical Data Demonstrating Efficacy in Tissue Regeneration at the Spring Symposium on Advanced Wound Care PR Newswire
Mar-19-15 09:33AM  Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI) at Insider Monkey +9.26%
Mar-12-15 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:57AM  Derma Sciences reports 4Q loss
07:41AM  Derma Sciences Reports Fourth Quarter and Year Ended Financial Results at noodls
07:30AM  Derma Sciences Reports Fourth Quarter and Year Ended Financial Results Business Wire
07:07AM  Q4 2014 Derma Sciences Inc Earnings Release - Time Not Supplied
Mar-11-15 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report
Mar-09-15 07:35AM  Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer at noodls
07:30AM  Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer Business Wire
Mar-04-15 11:09AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th at noodls
10:43AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th Business Wire
08:30AM  Derma Sciences to Present at the 27th Annual Roth Conference Business Wire
Mar-02-15 02:53PM  Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners at Insider Monkey
Jan-22-15 09:00AM  Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement PR Newswire
Jan-08-15 07:30AM  Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales Business Wire
Dec-17-14 09:03AM  New Consensus Guidelines and Practical Recommendations Published on the Optimal Use of Off-Loading in Diabetic Foot Ulcer Treatment PR Newswire
Nov-28-14 10:15AM  Insider Trading Alert - MNTA, DOC And DSCI Traded By Insiders at TheStreet
Nov-25-14 02:05PM  Derma Sciences To Participate in Two Upcoming Investor Conferences in December Business Wire
Nov-14-14 09:21AM  Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum Business Wire
Nov-10-14 07:39AM  Derma Sciences posts 3Q loss AP -6.18%
07:30AM  Derma Sciences Reports Third Quarter Financial Results Business Wire
Nov-07-14 05:27PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:19AM  Is a Surprise Coming for Derma Sciences (DSCI) This Earnings Season? Zacks
Nov-06-14 07:30AM  Newly Published Final CMS Payments for 2015 Favorably Impact Derma Sciences TCC-EZ® and AMNIOEXCEL® Business Wire
Nov-04-14 08:30AM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th Business Wire
Oct-23-14 11:58AM  Derma Sciences Presented Clinical Evidence And Data On Its Tissue Regeneration Products for Diabetic Foot Ulcers At Fall 2014 Symposium On Advanced Wound Care PR Newswire
Oct-17-14 02:37PM  Derma Sciences Showcases "Off-Loading Your Diabetic Foot Ulcer, An Actor's Story," a Patient Video Featuring Actor and Director Stephen Furst and his Experience with TCC-EZ® PR Newswire
Aug-12-14 09:16AM  Derma Sciences to Present at Canaccord Genuity 34th Annual Growth Conference on August 14 Business Wire
Aug-07-14 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today CCBN -7.20%
07:30AM  Derma Sciences Reports Second Quarter Financial Results Business Wire
07:07AM  Q2 2014 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Aug-06-14 05:09PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-01-14 07:30AM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 7th Business Wire
Jul-25-14 07:30AM  Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of Shareholders Business Wire
Jul-22-14 09:02AM  Derma Sciences announces Veterans Administration adds AMNIOEXCEL® to its Federal Supply Schedule Business Wire
Jun-19-14 07:47AM  Derma (DSCI) is in Overbought Territory: What's Next? Zacks
Jun-13-14 03:59PM  Derma Sciences, Inc. to Webcast June 17th Analyst Day Business Wire
May-29-14 09:00PM  [video] Derma Sciences CEO: Medihoney Sales Sweet and Getting Sweeter at TheStreet
May-23-14 04:50PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o EDGAR Online
May-22-14 11:10AM  Derma Sciences management to meet with Oppenheimer at theflyonthewall.com
May-09-14 07:39PM  Derma Sciences' (DSCI) CEO Ed Quilty on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
May-08-14 11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN -8.31%
07:36AM  Derma Sciences affirms FY14 net sales view $92M, consensus $91.78M at theflyonthewall.com
07:35AM  Derma Sciences reports Q1 EPS (46c), consensus (32c) at theflyonthewall.com
07:30AM  Derma Sciences Reports First Quarter Financial Results Business Wire
07:07AM  Q1 2014 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
May-07-14 05:18PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
May-06-14 11:32AM  Derma Sciences to Present at Sidoti Semiannual Micro-Cap Conference on May 9 Business Wire
May-02-14 05:02PM  Ed Quilty, CEO Of Derma Sciences, Outlines His Strategy To Build A Premier Wound Healing Company at Seeking Alpha
Apr-30-14 10:12AM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 8th Business Wire
07:00AM  3 Stocks Under $10 Making Big Moves at TheStreet
Apr-23-14 07:30AM  Derma Sciences Products to Be Featured in 10 Posters and Two Educational Programs at the SAWC Conference; Company Launches New Corporate Branding Campaign Business Wire
Mar-27-14 04:36PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Mar-14-14 04:34PM  Derma Sciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN
07:30AM  Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products Business Wire
07:07AM  Q4 2013 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Mar-13-14 05:30PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online
Mar-10-14 07:30AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 14th Business Wire
Mar-04-14 07:30AM  Derma Sciences to Present at the 26th Annual ROTH Conference Business Wire
Feb-28-14 10:05AM  Evaluate Biotech Stocks With Cynicism: Debjit Chattopadhyay at Seeking Alpha
Feb-19-14 01:17PM  Derma Sciences: A Not Well Followed Growth Company With Solutions For Diabetic Foot Ulcers at Seeking Alpha
Feb-05-14 03:30PM  3 Micro-Cap Stocks With Triple-Digit Upside StreetAuthority Network
Jan-31-14 06:34AM  Can Derma Sciences (DSCI) Continue to Rise? Zacks
Jan-30-14 05:43AM  Derma Sciences (DSCI) Jumps: Stock Rises 6.2% Zacks
Jan-29-14 10:17AM  Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment Business Wire +6.15%
Jan-27-14 05:30PM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit EDGAR Online
Jan-24-14 09:00AM  Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock Business Wire
Jan-23-14 04:01PM  Derma Sciences Announces Commencement of Public Offering of Common Stock Business Wire
Jan-21-14 04:27PM  DERMA SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Jan-17-14 05:13PM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ EDGAR Online
Jan-16-14 07:00AM  Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance, Provides Update on DSC127 Phase 3 Clinical Trials Business Wire
Jan-14-14 10:47AM  Stocks: Insiders Buy at Opko Health and DDR; Ironwood Pharmaceuticals Sees a Sale at Minyanville
09:18AM  Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products Business Wire
Dec-20-13 06:03PM  Nasdaq stocks posting largest volume increases AP
Dec-04-13 09:00AM  Derma Sciences to Present at the Oppenheimer & Co. Inc. 24th Annual Healthcare Conference Business Wire
Nov-25-13 10:45AM  INSERTING and REPLACING Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-14-13 05:55AM  Derma Sciences assumed with an Outperform at Oppenheimer at theflyonthewall.com
Nov-13-13 03:09PM  Derma Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN
07:30AM  Derma Sciences Reports Third Quarter Financial Results Business Wire
07:07AM  Q3 2013 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Nov-12-13 04:29PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Derma Sciences, Inc. operates as a tissue regeneration company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wounds; TCC-EZ system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair, reconstruction, and replacement; and AMNIOMATRIX that is used as a wound covering in the treatment of localized tissue defects. This segment also provides XTRASORB dressings, which convert fluid within the dressings to a gel and lock the exudates into the dressings; BIOGUARD dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. The company's Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; private-label wound care products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products. Its Pharmaceutical Wound Care segment develops DSC127, an angiotensin analog that is in Phase III clinical trials for the treatment of diabetic foot ulcers, and preclinical testing for scar reduction. The company sells its products to various health care providers, including wound care centers, extended care facilities, acute care facilities, home health care agencies, physicians' offices, nursing homes, hospitals, and clinics through direct sales and manufacturers' representatives, independent distributors, and retail channels in the United States, Canada, and the United Kingdom. Derma Sciences, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLS STEPHEN TDirectorMay 12Option Exercise3.368,75029,40098,359May 13 05:41 PM
CONJEEVARAM SRINIDirectorMay 12Option Exercise3.368,75029,40057,000May 13 05:40 PM
MOUSSA ROBERT GDirectorMar 18Option Exercise3.3611,25037,80053,500Mar 20 05:29 PM
Wolfenson BarrySee RemarksFeb 27Option Exercise4.006,25025,00084,568Mar 03 05:28 PM
COLE ROBERT CSee RemarksFeb 27Option Exercise4.0014,53258,12874,062Mar 03 05:25 PM
QUILTY EDWARD JPresident & CEOFeb 27Option Exercise4.0024,21996,876190,988Mar 03 05:21 PM
Eigner FredericExecutive VP - OperationsFeb 09Option Exercise4.0015,23560,94058,533Feb 11 05:14 PM
YETTER JOHN EEVP, Finance & CFOFeb 06Option Exercise4.0014,53258,12862,918Feb 11 05:16 PM
CONJEEVARAM SRINIDirectorDec 15Sale8.348,39169,98148,250Dec 16 06:35 PM
CONJEEVARAM SRINIDirectorDec 12Sale8.794,10936,11856,641Dec 16 06:35 PM
STAFFORD C RICHARDDirectorDec 04Sale8.596,07552,18430,250Dec 05 04:13 PM
STAFFORD C RICHARDDirectorNov 25Sale8.261,77514,66236,325Nov 26 04:37 PM
STAFFORD C RICHARDDirectorNov 18Sale8.593,25027,91838,100Nov 19 07:49 PM
STAFFORD C RICHARDDirectorNov 17Sale8.501,80015,30041,350Nov 19 07:49 PM
STAFFORD C RICHARDDirectorNov 14Sale8.455734,84243,150Nov 14 05:09 PM
STAFFORD C RICHARDDirectorNov 13Sale8.512,00017,02043,723Nov 14 05:09 PM
STAFFORD C RICHARDDirectorNov 12Sale8.472,50021,17545,723Nov 14 05:09 PM